CLOVER BIO-B: Monthly Return of Equity Issuer on Movements in Securities for the Month ended April 30, 2025

May 6 04:31 ET

CLOVER BIO-B: 2024 Annual Report

Apr 17 04:42 ET

CLOVER BIO-B: Monthly Return of Equity Issuer on Movements in Securities for the Month ended March 31, 2025

Apr 3 02:58 ET

CLOVER BIO-B: GRANT OF OPTIONS PURSUANT TO THE POST-IPO SHAREOPTION PLANANDGRANT OF RSUS PURSUANT TO THE RSU SCHEME

Apr 2 09:42 ET

CLOVER BIO-B: ANNUAL RESULTS ANNOUNCEMENTFOR THE YEAR ENDED DECEMBER 31, 2024

Mar 31 10:44 ET

CLOVER BIO-B: VOLUNTARY ANNOUNCEMENTCLOVER ANNOUNCES U.S. IND CLEARANCE ANDINITIATION OF REVACCINATION CLINICAL STUDY FORRSV VACCINE CANDIDATE SCB-1019

Mar 23 19:03 ET

CLOVER BIO-B: INSIDE INFORMATION

Mar 23 19:02 ET

CLOVER BIO-B: POSTPONEMENT OF BOARD MEETING DATE

Mar 23 19:02 ET

CLOVER BIO-B: DATE OF BOARD MEETING

Mar 12 05:30 ET

CLOVER BIO-B: Monthly Return of Equity Issuer on Movements in Securities for the Month ended February 28, 2025

Mar 5 04:43 ET

CLOVER BIO-B: Monthly Return of Equity Issuer on Movements in Securities for the Month ended January 31, 2025

Feb 6 02:59 ET

CLOVER BIO-B: GRANT OF RSUS PURSUANT TO THE RSU SCHEME

Jan 20 06:54 ET

CLOVER BIO-B: Monthly Return of Equity Issuer on Movements in Securities for the Month ended December 31, 2024

Jan 6 03:24 ET

CLOVER BIO-B: Monthly Return of Equity Issuer on Movements in Securities for the Month ended November 30, 2024

Dec 4, 2024 23:00 ET

CLOVER BIO-B: Monthly Return of Equity Issuer on Movements in Securities for the Month ended October 31, 2024

Nov 6, 2024 05:49 ET

CLOVER BIO-B: (Revised) Monthly Return of Equity Issuer on Movements in Securities for the Month ended September 30, 2024

Nov 6, 2024 05:49 ET

CLOVER BIO-B: VOLUNTARY ANNOUNCEMENT CLOVER ANNOUNCES POSITIVE CLINICAL DATA FOR RSV VACCINE CANDIDATE SCB-1019 COMPARED HEAD-TO-HEAD VERSUS GSK'S AREXVY

Oct 28, 2024 18:10 ET

CLOVER BIO-B: Monthly Return of Equity Issuer on Movements in Securities for the Month ended September 30, 2024

Oct 7, 2024 03:13 ET

CLOVER BIO-B: 2024 Interim Report

Sep 19, 2024 06:39 ET

CLOVER BIO-B: Letter to Registered Shareholders - New Arrangement of Electronic Dissemination of Corporate Communications and Reply Form

Sep 19, 2024 06:31 ET